NCT07301268
- Conditions
- Astrocytoma, Glioblastoma, Glioblastoma, IDH-wildtype, +17 more
- Locations
-
- Mayo Clinic in Rochester Rochester, Minnesota, United States
Clinical trial condition
Astrocytoma
Explore clinical trials studying Astrocytoma. Study availability and eligibility vary by location and protocol.
496 public trials
62 recruiting studies
Astrocytoma trial results
Recruiting
Tuvusertib in Astrocytoma With ATRX Mutation
NCT07417761
- Conditions
- Astrocytoma, Glioma, Neoplasms, +6 more
- Locations
-
- Hospital Universitario Son Espases Palma de Mallorca, Balearic Islands, Spain
- Hospital Universitario Vall d'Hebron Barcelona, Spain
- Hospital Clinic de Barcelona Barcelona, Spain
- Hospital Universitario de Cruces Barakaldo, Bizkaia, Spain
NCT05789394
- Conditions
- Astrocytoma, Astrocytoma, Grade IV, Glioblastoma, +10 more
- Locations
-
- Mayo Clinic in Florida Jacksonville, Florida, United States
NCT03603405
- Conditions
- Anaplastic Astrocytoma, Astrocytoma, Glioblastoma, +8 more
- Locations
-
- Houston Methodist Neurological Institute Houston, Texas, United States
NCT03596086
- Conditions
- Astrocytoma, Astrocytoma, Grade III, Glioblastoma, +9 more
- Locations
-
- Houston Methodist Neurological Institute Houston, Texas, United States
NCT05345002
- Conditions
- Astrocytoma, Glioma, IDH Mutation, +8 more
- Locations
-
- University of Pennsylvania Philadelphia, Pennsylvania, United States
NCT05957679
- Conditions
- Astrocytoma, Central Nervous System Diseases, Central Nervous System Neoplasms, +24 more
- Locations
-
- Shengjing Hospital Shenyang, Liaoning, China
Recruiting
SJ901: Evaluation of Mirdametinib in Children, Adolescents, and Young Adults With Low-Grade Glioma
NCT04923126
- Conditions
- Astrocytoma, Brain Diseases, Brain Neoplasms, +20 more
- Locations
-
- St. Jude Children's Research Hospital Memphis, Tennessee, United States
NCT05683808
- Conditions
- Astrocytoma, Cardiovascular Diseases, Embolism and Thrombosis, +12 more
- Locations
-
- University of Vermont Medical Center Burlington, Vermont, United States
Recruiting
Study of Pembrolizumab and M032 (NSC 733972)
NCT05084430
- Conditions
- Anaplastic Astrocytoma, Astrocytoma, Disease Attributes, +14 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States